Skip to main content

Table 1 Functional profile of the imatinib-induced transcriptional response

From: Threshold-free high-power methods for the ontological analysis of genome-wide gene-expression studies

KS

CM

AD

ZA

ZK

ZC

D1

D2

D3

D4

D5

D6

ΔZC

ΔZK

Size*

Biological process (GO)

+

+

          

-1.00

-1

3

'de novo' IMP biosynthesis

+

+

+

+

+

+

+

+

+

+

+

 

+1.00

+1

5

Heme biosynthesis

     

+

      

-1.00

-1

3

Inactivation of MAPK activity

+

+

          

-1.00

-1

5

Intracellular transport

     

+

      

-1.00

-1

5

Negative regulation of apoptosis

 

+

          

-0.87

-1

22

Regulation of transcription

+

+

          

-0.97

-1

7

Regulation of translational initiation

+

+

          

-1.00

-1

7

Translational initiation

KS

CM

AD

ZA

ZK

ZC

D1

D2

D3

D4

D5

D6

ΔZC

ΔZK

Size*

Biological process (ABI)

+

+

  

+

       

+1.00

+1

17

Hematopoiesis

     

+

  

+

+

+

 

-1.00

-1

25

Inhibition of apoptosis

    

+

+

  

+

+

+

 

-0.89

-1

9

Macrophage-mediated immunity

    

+

+

  

+

+

+

 

-0.99

-1

37

MAPKKK cascade

+

+

+

 

+

       

-1.00

-1

21

Protein complex assembly

    

+

       

-1.00

-1

4

rRNA metabolism

KS

CM

AD

ZA

ZK

ZC

D1

D2

D3

D4

D5

D6

ΔZC

ΔZK

Size*

Molecular function (GO)

+

+

+

+

        

-0.90

-1

257

ATP binding

+

           

-0.61

-1

17

ATP-dependent helicase activity

+

+

+

+

+

       

-0.91

-1

57

GTPase activity

+

+

+

+

+

       

-1.00

-1

3

Protein kinase C activity

     

+

      

-1.00

-1

6

Protein tyrosine phosphatase activity

+

+

+

+

+

+

      

-0.93

-1

95

RNA binding

+

+

+

+

+

       

-0.91

-1

14

Translation initiation factor activity

KS

CM

AD

ZA

ZK

ZC

D1

D2

D3

D4

D5

D6

ΔZC

ΔZK

Size*

Molecular function (ABI)

           

+

-0.87

-1

18

Protein kinase

KS

CM

AD

ZA

ZK

ZC

D1

D2

D3

D4

D5

D6

ΔZC

ΔZK

Size*

Molecular pathway (ABI)

  

+

         

-1.00

-1

23

EGR receptor signaling pathway

  

+

+

+

+

  

+

+

+

+

-1.00

-1

8

Interferon-gamma signaling pathway

 

+

+

+

+

       

-1.00

-1

3

Metabotropic glutamate receptor group I pathway

KS

CM

AD

ZA

ZK

ZC

D1

D2

D3

D4

D5

D6

ΔZC

ΔZK

Size*

Cellular component (GO)

 

+

+

+

 

+

      

-1.00

-1

147

Cytoplasm

  

+

+

+

+

      

+1.00

+1

4

Kinesin complex

   

+

+

+

  

+

+

+

+

+0.73

+1

9

Microtubule associated complex

 

+

+

+

 

+

      

-0.93

-1

23

Nuclear pore

  

+

+

 

+

      

-1.00

-1

24

Nucleolus

   

+

+

       

-1.93

-1

21

Ribonucleoprotein complex

  1. Gene categories in the imatinib data (P.H., B.N., A Andersson, C Lassen, U Gullberg, and T.F., unpublished work) called significant by at least one of the category-detection methods (25% false-discovery rate; significance indicated by +). Key observations: (1) The choice of method strongly influences the results. (2) The method-method agreements observed on real data approximately follow those observed in the simulations (see Figure 3). (3) Several detected categories are consistent with literature data on BCR/ABL1-mediated leukemogenesis, supporting the validity of the methodology (see main text). (4) The table illustrates the use of indicator functions to determine the direction of transcriptional deviation in detected categories. In this case, ZC and ZK exemplify soft indicators (available for AD, CM, ZA, and ZC) and the less informative hard indicators (available for KS and ZK), respectively (see also Figure 5). *By size, we mean the number of unique genes (Entrez Gene IDs) within the category.